Purchase Order 75N93023P01344

Award Date 9/25/23
Potential Completion Date 10/24/23
Potential Value $25K
Ultimate Awardee
Not listed
PSC Category
6810 - Chemicals
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $16,106.50 firm fixed price purchase order to 10X Genomics, Inc., doing business as 10X Genomics, located in Pleasanton, California. The contract has a period of performance from September 25, 2023 through October 24, 2023. It carries a total small business set aside designation. As a leading life science technology company, 10X Genomics will provide its...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $24,324 firm fixed price purchase order to 10X Genomics, Inc. for unspecified products or services in support of the agency's research programs. The contract has a period of performance from September 26, 2023 through October 25, 2023 and will be performed in Pleasanton, California. This sole source award was set aside for total small businesses. No additional...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $24,626 firm fixed price purchase order to 10X Genomics, Inc., doing business as 10X Genomics, of Hamilton, Montana. The contract has a period of performance from September 25, 2023 through October 24, 2023 and is designated as a total small business set aside. As a leading life sciences technology company, 10X Genomics will likely provide genomic analysis...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $14,889.50 firm fixed price purchase order to 10X Genomics, Inc. for 10X Genomics Chromium Next Gem products. The place of performance will be 10X Genomics' facilities in Pleasanton, California, with work expected to be completed by February 14, 2024. As the National Institute of Allergy and Infectious Diseases conducts research on preventing, diagnosing and...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $24,324 firm fixed price purchase order to 10X Genomics, Inc. for Chromium Kits. 10X Genomics will deliver its genomic analysis products to support NIH research efforts through September 2024. As the prime contractor, 10X Genomics will provide its proprietary kits and associated services from its Pleasanton, California location. The award was made using an...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $39,514.25 firm fixed price purchase order to 10X Genomics, Inc., a small business that specializes in life sciences technology and genomic analysis platforms. The contract is for the delivery of a Chromium Next GEM Reagent Bundle, which supports single-cell and spatial analysis applications. This award appears to be part of a larger indefinite delivery...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $12,306.50 firm fixed-price purchase order to 10X Genomics, Inc., located in Pleasanton, California, to provide Chromium Kits. The contract period of performance runs from August 28, 2023 through August 27, 2024. 10X Genomics will deliver its Chromium Kits to support the NIH's research efforts in the areas of allergy and infectious disease. No...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to 10X Genomics, Inc. for $194,873.00. The order is for a range of 10X Genomics' single-cell analysis products and services to support COVID-19 research, including library construction kits, Chromium Next GEM Single Cell kits, and associated reagents and instruments. This procurement was set aside for small...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a firm fixed price purchase order worth $35,916.00 to 10X Genomics, Inc., a small business manufacturer of life sciences products and services. The award, which was set aside for small businesses, is for the supply of 10X Genomics' Visium HD, Mouse Transcriptome, 6.5 mm product under a brand name restriction. This procurement was conducted using...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $30,539 firm fixed price purchase order to 10X Genomics, Inc. for the acquisition of Chromium Next GEM Single Cell 5' Kits and Library Construction Kits. Under the terms of the contract, 10X Genomics will provide 16 reactions of the Chromium Next GEM Single Cell 5' Kit v2 and 48 reactions of the Library Construction Kit. The place of performance is 10X...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $25,000 firm fixed price purchase order to 10X Genomics, Inc. for products and/or services to be delivered between September 25, 2023 and October 24, 2023. 10X Genomics, located in Rockville, Maryland, will serve as the prime contractor on this contract, which has been set aside for total small businesses. No additional details were provided on subcontractors or the scope of work. This award is likely in support of NIH/NIAID's infectious disease research efforts.

Generated 12/20/23, 5:25 AM